Glioblastoma, IDH-wildtype Clinical Trials in Jacksonville, Florida
4 recruitingJacksonville, Florida
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-WildtypeRecurrent MGMT-Methylated Glioblastoma
National Cancer Institute (NCI)97 enrolled36 locationsNCT05432804
Recruiting
Phase 2
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Glioblastoma, IDH-wildtype
ECOG-ACRIN Cancer Research Group100 enrolled12 locationsNCT06319027
Recruiting
Not Applicable
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Glioblastoma, IDH-wildtypeWHO Grade 4 Glioma
Mayo Clinic116 enrolled3 locationsNCT07091864
Recruiting
Phase 1
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-WildtypeAstrocytoma, Grade IV
Mayo Clinic20 enrolled1 locationNCT05789394